E1505: Adjuvant Chemotherapy plus /- Bevacizumab for Early Stage NSCLC: Updated Chemotherapy Subset Analysis Wakelee, H., Dahlberg, S., Keller, S., Tester, W., Aisner, S., Rothman, J., Patel, J., Delaune, R., Mcdermott, S., Shafqat, A., Perez-Soler, R., Chapman, A., Kasbari, S., Traynor, A., Evans, T., Horn, L., Graziano, S., Gandara, D., Adjei, A., Butts, C., Leighl, N., Ramalingam, S., Schiller, J. ELSEVIER SCIENCE INC. 2019: S271

View details for Web of Science ID 000492162201228